As presbyopia-correcting drops from different companies go through clinical trials and receive U.S. marketing approval, there is excitement about what these drops could mean for middle-aged presbyopes who dislike reading glasses.
But there are at least three key subsets of the pseudophakic patient population that could also benefit from pupil-modulating drops.
Post-corneal refractive surgery patients already know the value of spectacle independence, but many of them are not good candidates for premium lenses. Biometry in post-RK eyes, for example, can change from day to day and vision can